Patel, M.D., Ph.D., of Brigham and Women’s Hospital and the Dana Farber Tumor Institute, Boston, and co-workers conducted a study to compare the prognostic need for Gleason score 7 with tertiary quality 5 vs. Other Gleason scores with respect to time to prostate-specific antigen failure . From 1989 to 2005, 2,370 men with numerous tumor grades and prostate malignancy that had not spread to close by lymph nodes or somewhere else in the body, underwent therapy with radiation or surgery therapy with or without hormonal therapy. Gleason scores were assigned to the prostate needle biopsy specimens. Related StoriesMeat-rich diet may increase kidney cancer riskFDA grants accelerated authorization for Tagrisso to treat individuals with advanced NSCLCCrucial transformation in single DNA bottom predisposes children to aggressive form of cancerThe researchers found that males with Gleason score 7 and tertiary grade 5 disease had a considerably shorter period to PSA failing than men with 7 without tertiary grade 5 ; or score of 6 or much less .Action announces European phase I scientific trial for Stargardt’s disease using retinal pigment epithelial cells Advanced Cell Technology, Inc. , a innovator in neuro-scientific regenerative medicine, announced treatment of the first patient in the 3rd dosage cohort today, and seventh patient general, in its European Phase I medical trial for Stargardt's macular dystrophy using retinal pigment epithelial cells derived from individual embryonic stem cells . The patient was injected with 150,000 hESC-derived RPE cells, as compared with the 100,000-cell dose used in patients of the second cohort. On Friday The surgery was performed, April 19, without any complications, and the patient is recovering uneventfully.